Authors:
CONNOLLY SJ
CAIRNS J
GENT M
ROBERTS R
YUSUF S
JULIAN DG
CAMM AJ
FRANGIN G
JANSE MJ
MUNOZ A
SCHWARTZ PJ
SIMON P
ROSENBAUM MB
ELIZARI MV
CAGIDE A
GIROTTI LA
MARTINEZ JM
CARBAJALES J
SCAPIN O
GARGUICHEVICH J
HAUAD S
BELZITI C
SINISI A
CEREMUZYNSKI L
BUDAJ A
KLECZAR E
NARTOWICZ E
SMIELAKKOROMBEL J
DYDUSZYNSKI A
MACIEJEWICZ J
KOKOWICZ P
NAVARROLOPEZ F
COSIN J
MARRUGAT J
GUINDO J
DELUNA AB
PFISTERER M
OSSWALD S
BURCKHARDT D
BURKART F
HOCKINGS B
GEORGE T
MAHROUS F
TAYLOR R
HAJAR H
SINGH S
FLETCHER R
FISHER S
SINGH B
DOVAL H
NUL D
GRANCELLI H
PERRONE S
BORTMAN G
CURIEL R
RAMOS J
GAMBARTE A
GENTILE A
SIRENA J
TIBALDI M
TOPLIKAR J
NICKLAS J
MCKENNA W
STEWART R
MICKELSON J
DAS S
SCHORK A
KRICKLER S
QUAIN L
MORADY F
PITT B
HAMER A
ARKLES L
JOHNS J
MORRISON L
ROBERTS J
Citation: Sj. Connolly et al., EFFECT OF PROPHYLACTIC AMIODARONE ON MORTALITY AFTER ACUTE MYOCARDIAL-INFARCTION AND IN CONGESTIVE-HEART-FAILURE - METAANALYSIS OF INDIVIDUAL DATA FROM 6500 PATIENTS IN RANDOMIZED TRIALS, Lancet, 350(9089), 1997, pp. 1417-1424
Authors:
GARGUICHEVICH JJ
RAMOS JL
GAMBARTE A
GENTILE A
HAUAD S
SCAPIN O
SIRENA J
TIBALDI M
TOPLIKAR J
Citation: Jj. Garguichevich et al., EFFECT OF AMIODARONE THERAPY ON MORTALITY IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION AND ASYMPTOMATIC COMPLEX VENTRICULAR ARRHYTHMIAS - ARGENTINE PILOT-STUDY OF SUDDEN-DEATH AND AMIODARONE (EPAMSA), The American heart journal, 130(3), 1995, pp. 494-500
Authors:
VANDEWERF F
SANTOPINTO J
CORDERO FA
FAINSTEIN D
CORINALDESI A
ZAVATTI D
LUPPI O
IPARRAGUIRRE HP
HIRSCHSON A
PIOMBO A
LAPUENTE A
KRITZER J
SAMPO E
AGINSKY R
TAJER C
CERCOS H
BALLESTRINI A
GUZMAN L
MELE E
BOND M
THOMPSON A
BAEFF O
CORTEZ A
RYBA D
LOWENSTEIN J
PENSA C
ZAMUZ A
LIMA RF
MARMONTI M
UBALDINI J
LOPEZ JG
BERRA FC
YANGUAS M
PALMA AL
CASTILLA J
CONCI E
GAVIER MD
BASTIANELLI R
VERGOTTINI J
BADARACCO R
SANJURJO M
SOSA C
VENTURA A
CARTASEGNA L
ABALDE J
TORRIJOS J
PERRINO O
ZOCCO J
MONTENEGRO D
CORSIGLIA D
RIGHETTI L
BADRA R
GARCIA M
ORTEGO R
HIDALGO J
ROMERO G
RODENAS P
ROSSI O
PUCCINI V
DIEZ A
LOCATELLI H
BRUERA E
ROBIOLO A
VILLARES J
CUNEO C
FALU E
BECKER C
MONGE A
MINEN O
CASANAS R
FERNANDEZ R
IBARZABAL U
SIRENA J
ALVAREZ A
CASTELLANOS R
MEULI M
ROMERO M
QUINTANA R
SOUSA JEMR
PIEGAS LS
AVEZUM A
TIMERMAN R
ROMANO ER
CARVALHO AC
FAELLI D
FARRAN J
NICOLAU JC
BRAGA J
SILVA JAF
BODANESE LC
RIMENTEL P
SANDOYA E
LLUBERAS R
AMARAL DC
RODRIGUEZ JC
DIAZ R
PAOLASSO E
VERCAMMEN E
BROWER R
FUSTER V
MURRAY G
TOPOL E
WHITE H
POLLOLA J
PAVIOTTI C
AIZPURUA M
GONZALEZ N
GUIRAO F
RODRIGUEZ A
SARMIENTO R
LONDERO H
SOUSA AGMR
PINTO IM
MOLTENI S
SCHWARTZ H
SZWARCER E
CANALA M
ESCALANTE L
AGGIO M
BARTOMIOLI M
GIULIANI R
MARELLO L
VIDAL H
ORLANDO S
WOODS A
NATTERO G
VILLAFANE S
LANARI E
GUTNISKY E
SAVARINO M
DEKROLLE S
DEPAOLETTI D
MARCIPAR D
HARRACA M
MORALES M
GENOVESI A
BAITCH L
SWING E
MANRIQUE R
Citation: F. Vandewerf et al., RANDOMIZED TRIAL OF RIDOGREL, A COMBINED THROMBOXANE A(2) SYNTHASE INHIBITOR AND THROMBOXANE A(2) PROSTAGLANDIN ENDOPEROXIDE RECEPTOR ANTAGONIST, VERSUS ASPIRIN AS ADJUNCT TO THROMBOLYSIS IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION - THE RIDOGREL VERSUS ASPIRIN PATENCY TRIAL (RAPT)/, Circulation, 89(2), 1994, pp. 588-595